You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information. Switch to the US site. 

  • The share
  • Arjo B
  • 26 Okt 2020 17:29
  • 5,62 EUR (-0,94%)

Arjo announces date of 2020 Q3 report and conference call

Arjo will issue its Q3 report for 2020 on Wednesday October 28 at 07:00 CET, followed by a conference call at 08:00 CET, hosted by Joacim Lindoff, President & CEO, and Daniel Fäldt, CFO.

We invite fund managers, analysts and the media to participate in the conference call. Please see details below to join the conference. 

Swedish dial-in number: +46 8 519 993 83
USA: +1 833 526 8383
UK: +44 3333 009 266

During the telephone conference, a presentation will be held. To access the presentation, please use this link: https://tv.streamfabriken.com/arjo-q3-2020

Alternatively, use the following link to download the presentation: 
https://www.arjo.com/int/about-us/investors/reports--presentations/2020/

Agenda

07:45              Call in to the conference
08:00              Review of the Q3 report
08.30              Q&A
09.00              End of conference

A recorded version of the conference is accessible for 3 years via the following link: https://tv.streamfabriken.com/arjo-q3-2020

For more information, please contact:                                                                                               

Kornelia Rasmussen, EVP Marketing Communications & Public Relations
Tel: +46(0)10 335 4810
E-mail:
kornelia.rasmussen@arjo.com

Maria Nilsson, Investor Relations & Corporate Communications
Tel: +46 (0)10 335 4866
Email:
maria.nilsson@arjo.com  

About Arjo
At Arjo, we are committed to improving the everyday lives of people affected by reduced mobility and age-related health challenges. With products and solutions that ensure ergonomic patient handling, personal hygiene, disinfection, diagnostics, and the effective prevention of pressure ulcers and venous thromboembolism, we help professionals across care environments to continually raise the standard of safe and dignified care. Arjo has approximately 6,000 employees worldwide and customers in over 100 countries. In 2019, Arjo sales amounted to SEK 8.9 billion. Arjo is listed on Nasdaq Stockholm and its head office is located in Malmö, Sweden. Everything we do, we do with people in mind. www.arjo.com

Download as PDF